lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

New Onset Anosmia and Ageusia in Adult Patients Diagnosed with SARS-CoV-2 in a London Community and Secondary Care Population

18 Pages Posted: 18 May 2020

See all articles by Aatish Patel

Aatish Patel

Chelsea and Westminster NHS Foundation Trust

Esmita Charani

Imperial College London - NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance

David Ariyanayagam

Imperial College London - School of Medicine

Ahmed Abdulaal

Chelsea and Westminster NHS Foundation Trust

Sarah Denny

Chelsea and Westminster NHS Foundation Trust; North West London Pathology

Nabeela Mughal

Chelsea and Westminster NHS Foundation Trust; Imperial College London - NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance; North West London Pathology

Luke Moore

Imperial College London

More...

Abstract

Background: We investigated the prevalence of anosmia and ageusia in adult patients with a laboratory confirmed diagnosis of severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2).

Methods: A retrospective observational analysis was conducted amongst patients and their household contacts across a central London population diagnosed with SARS-CoV-2 and admitted to hospital or managed in the community during March 1 - April 1, 2020. Symptomatology and duration were extracted from routinely collected clinical data. Descriptive statistics were used.

Findings: Of 386 patients with a laboratory diagnosis of SARS-CoV-2, 141 (92 community patients, 49 discharged inpatients) had evaluable data and were included for analysis. 77/141 (55%) reported anosmia and ageusia; nine reported only ageusia and three only anosmia. The mean duration of symptoms (as defined by the Public Health England case definition for SARS-CoV-2) was 13·1 days (0-33). The mean onset of anosmia in relation to onset of SARS-CoV-2 symptoms was 4·6 days (0-21). Duration of anosmia was 12·3 days (0-30). Duration of SARS-CoV-2 symptoms in community patients was 11·5 days (0-28) versus 16·7 days (0-33) in admitted patients. As of April 1, 45 patients had ongoing SARS-CoV-2 symptoms and/or anosmia. 107/141 (76%) patients had one or more household contacts during their isolation period. Of these, 185 non-tested household contacts, 79 (43%) had SARS-CoV-2 symptoms with 46/79 (58%) reporting anosmia. Six household contacts had anosmia only.

Interpretation: More than half of SARS-CoV-2 positive patients reported anosmia and ageusia. These findings suggest anosmia and ageusia should be added to case definitions for SARS-CoV2 and guide self-isolation protocols. This adaptation may be integral to case finding in the absence of population level testing. Until a time where we have successful population level vaccination coverage, these steps remain essential both in this pandemic and subsequent waves.Funding No specific funding was obtained for this work.

Funding Statement: This research did not receive any grant from funding agencies in the public or commercial sectors.

Declaration of Interests: EC has received speaker fees from bioMerieux (2019). NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). LSPM has consulted for bioMerieux (2013), DNAelectronics (2015-18), Dairy Crest (2017–2018), Umovis Lab (2020), received speaker fees from Profile Pharma (2018- 2019) and Pfizer (2018-2020), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2019), and Leo Pharma (2016), and received educational support from Eumedica (2016–2018). AP, DLA, AA none to declare.

Ethics Approval Statement: Data was collected as part of routine care by the responsible clinical team. No patient identifiable data is reported in this analysis. The need for written informed consent was waived by the Research Governance Office of Chelsea & Westminster NHS Foundation Trust.

Keywords: COVID-19, Coronavirus, Ear, nose and throat [MeSH]

Suggested Citation

Patel, Aatish and Charani, Esmita and Ariyanayagam, David and Abdulaal, Ahmed and Denny, Sarah and Mughal, Nabeela and Moore, Luke, New Onset Anosmia and Ageusia in Adult Patients Diagnosed with SARS-CoV-2 in a London Community and Secondary Care Population (4/15/2020). Available at SSRN: https://ssrn.com/abstract=3578759 or http://dx.doi.org/10.2139/ssrn.3578759

Aatish Patel (Contact Author)

Chelsea and Westminster NHS Foundation Trust ( email )

London
United Kingdom

Esmita Charani

Imperial College London - NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance

London
United Kingdom

David Ariyanayagam

Imperial College London - School of Medicine

South Kensington Campus
Exhibition Road
London, Greater London SW7 2AZ
United Kingdom

Ahmed Abdulaal

Chelsea and Westminster NHS Foundation Trust

London
United Kingdom

Sarah Denny

Chelsea and Westminster NHS Foundation Trust

London
United Kingdom

North West London Pathology

United Kingdom

Nabeela Mughal

Chelsea and Westminster NHS Foundation Trust

London
United Kingdom

Imperial College London - NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance

London
United Kingdom

North West London Pathology

United Kingdom

Luke Moore

Imperial College London

South Kensington Campus
Exhibition Road
London, Greater London SW7 2AZ
United Kingdom

Click here to go to TheLancet.com

Paper statistics

Abstract Views
463
Downloads
39